藍海華騰(300484.SZ):控股股東邱文淵及其一致行動人擬合計減持不超過343萬股股份
格隆匯9月12日丨藍海華騰(300484.SZ)公佈,公司控股股東邱文淵先生及其一致行動人華騰投資、中騰投資,合計持有公司股份3444.95萬股,佔公司總股本比例16.59%,擬合計減持股份數量不超過343萬股,佔公司總股本比例1.65%。其中,邱文淵先生擬集中競價減持30萬股,佔公司總股本比例0.14%,擬大宗交易(包含自身內部轉讓部分)減持120萬股,佔公司總股本比例0.58%;華騰投資擬集中競價減持144萬股,佔公司總股本比例0.69%;中騰投資擬集中競價減持49萬股,佔公司總股本比例0.24%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.